{
  "items": [
    {
      "title": "4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off",
      "description": "It's always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a particularly opportune time.  With a volatile equity market and a potential recession looming due to the impact of tariffs, dividend stocks can help strengthen any portfolio.  With that as a backdrop, let's consider four excellent income stocks that investors can buy amid the current sell-off: AbbVie (NYSE: ABBV), Amgen (NASDAQ: AMGN), Bristol Myers Squibb (NYSE: BMY), and Zoetis (NYSE: ZTS).",
      "published_utc": "2025-04-27T06:05:00",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=4b343700d61184c8820b2648510b9b4b9daead66835bdbcda884421d1aead106",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 134104516,
      "datetime": 1745705100
    },
    {
      "title": "Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment",
      "description": "Amgen (NasdaqGS:AMGN) recently announced a significant $900 million expansion in its Ohio manufacturing facility, aiming to strengthen its biomanufacturing capabilities. This investment is part of a strategic focus on enhancing U.S. manufacturing, alongside its $1 billion commitment to a new plant in North Carolina. Over the past quarter, Amgen's stock price moved by 2%, while the broader market increased by 8%. Although the company's investment plans signal long-term growth, this moderate...",
      "published_utc": "2025-04-27T01:16:19",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=f1b0e211be19882e44eb717ebc2d1f898c3c46cc6429bc3f42079e4ec555bfa3",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 134104590,
      "datetime": 1745687779
    },
    {
      "title": "Novo Nordisk: Examining Tariff And Pricing Risks",
      "description": "",
      "published_utc": "2025-04-26T16:50:33",
      "source": "SeekingAlpha",
      "url": "https://finnhub.io/api/news?id=4959a9af926c223a27f36e094f6b83b35e55adb6ab39736fc8461b7df81548ce",
      "category": "company",
      "image": "",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 134099617,
      "datetime": 1745657433
    }
  ],
  "metadata": {
    "cached_at": "2025-09-25T07:36:04.030334+00:00",
    "cache_key": "news_c8d6efd9d30e7c1884155630ac446a90",
    "count": 3
  }
}